Novel CNS Biomarkers Summit Europe
Hosted by Hanson Wade
- 30 November – 2 December 2026
Add to calendar
Welcome to kongre.net - Hilton London Olympia, London, United Kingdom
- Clinical MedicineNeurologyBasic MedicinePharmacology & Toxicology
Let others know you'll be there. This does not register you for the event.
Registration
Registration is handled by the organiser
Go to registration(opens in a new tab)See registration feesKey facts
Novel CNS Biomarkers Summit Europe is a summit held 30 November – 2 December 2026 in Hilton London Olympia, London, United Kingdom, organised by Hanson Wade.
- Dates:
- 30 November – 2 December 2026
- Format:
- In person
- Venue:
- Hilton London Olympia, London, United Kingdom
- Subjects:
- Neurology, Pharmacology & Toxicology
- Organiser:
- Hanson Wade
- Official website:
- cns-biomarkers-europe.com
The Novel CNS Biomarkers Summit Europe is a premier gathering dedicated exclusively to the advancement of fluid, imaging, and digital biomarkers for CNS drug development. Organised by Hanson Wade, the event takes place from 30th November to 2nd December 2026 at the Hilton London Olympia in London, United Kingdom. It brings together over 60 biomarker, translational medicine, neuroscience, and clinical development leaders from across Europe to address the high rate of clinical trial failures and accelerate precision-driven drug development for indications such as Alzheimer's disease, Parkinson's disease, ALS, and schizophrenia.
Conference theme
Programme highlights
View full programmeSpeakers
View all 16 speakersOrganiser and contact
Contact
- Event secretary:
- Isobel Slater
- Email:
- [email protected]
Advertisement
Related events
- EFIC Congress 2027 - Pain in Europe XVGlasgow, United Kingdom21–23 Apr 2027
- Cell Press Symposia: Drugging the undruggableOxford, United Kingdom12–14 Jul 2027
- 11th Saudi Pediatric Neurology Society Conference and WorkshopsJeddah, Saudi Arabia11–14 Nov 2026
- 31st World Congress on Parkinson’s Disease and Related Disorders 2026Milan, Italy11–14 Nov 2026
- Biomarker Assessment for an Early Biological Diagnosis of Alzheimer’s DiseaseVienna, Austria12–13 Nov 2026
- 19th National Congress of Stroke and Neurovascular DiseasesAntalya, Türkiye12–15 Nov 2026